• Je něco špatně v tomto záznamu ?

Detection of microemboli in patients with acute ischaemic stroke and atrial fibrillation suggests poor functional outcome

P. Castro, J. Ferreira, B. Malojcic, D. Bazadona, C. Baracchini, A. Pieroni, D. Skoloudik, E. Azevedo, M. Kaps

. 2024 ; 9 (2) : 409-417. [pub] 20231227

Jazyk angličtina Země Anglie, Velká Británie

Typ dokumentu časopisecké články, multicentrická studie

Perzistentní odkaz   https://www.medvik.cz/link/bmc24013805

INTRODUCTION: We investigated the burden of microembolic signals (MES) in patients with acute ischaemic stroke (AIS) and atrial fibrillation (AF), assessing their impact on functional outcomes. PATIENTS AND METHODS: This multicentre international prospective cohort study involved patients with AIS and either a known or newly diagnosed anticoagulant-naïve AF. All centres utilised the same transcranial Doppler machine for 1-h monitoring with bilateral 2 MHz probes within 24 h of symptom onset. Recordings underwent MES analysis by a blinded central reader. The primary objectives were to ascertain the MES proportion and its association with functional outcomes assessed by the modified Rankin scale (mRS) score at 90 days. RESULTS: Between September 2019 and May 2021, we enrolled 61 patients, with a median age of 78 years (interquartile range 73-83) and a median stroke severity score of 11 (interquartile range 4-18). MES were observed in 14 patients (23%), predominantly unilateral (12/14, 86%), with a median rate of 6 counts/hour (interquartile range 4-18). MES occurrence was higher post-thrombectomy and among those with elevated brain natriuretic peptide levels (p < 0.05). A worse mRS score of 3-6 was more frequent in patients with MES, occurring in 11/14 (79%), compared to those without MES, 20/47 (43%), with an adjusted odds ratio of 5.04 (95% CI, 1.15-39.4), p = 0.04. CONCLUSIONS: Nearly a quarter of patients with AIS and AF exhibited silent microembolization after the index event. Detecting MES within 24 h post-stroke (using transcranial Doppler) could signify a marker of poor functional outcomes. Subsequent trials will assess if very early antithrombotic treatment might enhance outcomes in this highly selective group of cardioembolic stroke patients. (Clinicaltrials.gov ID: NCT06018090).

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc24013805
003      
CZ-PrNML
005      
20240905134346.0
007      
ta
008      
240725s2024 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1177/23969873231220508 $2 doi
035    __
$a (PubMed)38149620
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Castro, Pedro $u Department of Neurology, Centro Hospitalar Universitário de São João, Faculty of Medicine of University of Porto, Porto, Portugal $1 https://orcid.org/0000000314012398
245    10
$a Detection of microemboli in patients with acute ischaemic stroke and atrial fibrillation suggests poor functional outcome / $c P. Castro, J. Ferreira, B. Malojcic, D. Bazadona, C. Baracchini, A. Pieroni, D. Skoloudik, E. Azevedo, M. Kaps
520    9_
$a INTRODUCTION: We investigated the burden of microembolic signals (MES) in patients with acute ischaemic stroke (AIS) and atrial fibrillation (AF), assessing their impact on functional outcomes. PATIENTS AND METHODS: This multicentre international prospective cohort study involved patients with AIS and either a known or newly diagnosed anticoagulant-naïve AF. All centres utilised the same transcranial Doppler machine for 1-h monitoring with bilateral 2 MHz probes within 24 h of symptom onset. Recordings underwent MES analysis by a blinded central reader. The primary objectives were to ascertain the MES proportion and its association with functional outcomes assessed by the modified Rankin scale (mRS) score at 90 days. RESULTS: Between September 2019 and May 2021, we enrolled 61 patients, with a median age of 78 years (interquartile range 73-83) and a median stroke severity score of 11 (interquartile range 4-18). MES were observed in 14 patients (23%), predominantly unilateral (12/14, 86%), with a median rate of 6 counts/hour (interquartile range 4-18). MES occurrence was higher post-thrombectomy and among those with elevated brain natriuretic peptide levels (p < 0.05). A worse mRS score of 3-6 was more frequent in patients with MES, occurring in 11/14 (79%), compared to those without MES, 20/47 (43%), with an adjusted odds ratio of 5.04 (95% CI, 1.15-39.4), p = 0.04. CONCLUSIONS: Nearly a quarter of patients with AIS and AF exhibited silent microembolization after the index event. Detecting MES within 24 h post-stroke (using transcranial Doppler) could signify a marker of poor functional outcomes. Subsequent trials will assess if very early antithrombotic treatment might enhance outcomes in this highly selective group of cardioembolic stroke patients. (Clinicaltrials.gov ID: NCT06018090).
650    _2
$a lidé $7 D006801
650    _2
$a senioři $7 D000368
650    12
$a fibrilace síní $x komplikace $7 D001281
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a mužské pohlaví $7 D008297
650    12
$a ischemická cévní mozková příhoda $x diagnostické zobrazování $x terapie $7 D000083242
650    _2
$a senioři nad 80 let $7 D000369
650    _2
$a prospektivní studie $7 D011446
650    12
$a ultrasonografie dopplerovská transkraniální $x metody $7 D017585
650    _2
$a intrakraniální embolie $x diagnostické zobrazování $7 D020766
650    _2
$a trombektomie $7 D017131
655    _2
$a časopisecké články $7 D016428
655    _2
$a multicentrická studie $7 D016448
700    1_
$a Ferreira, J $u UnIC@RISE, Department of Clinical Neurosciences and Mental Health, Faculty of Medicine of University of Porto, Porto, Portugal $1 https://orcid.org/0000000292868987
700    1_
$a Malojcic, Branko $u Department of Neurology, Hospital Centre Zagreb, Zagreb, Croatia
700    1_
$a Bazadona, Danira $u Department of Neurology, Hospital Centre Zagreb, Zagreb, Croatia
700    1_
$a Baracchini, Claudio $u Stroke Unit and Neurosonology Laboratory, University of Padua School of Medicine, Padova. Italy
700    1_
$a Pieroni, Alessio $u Stroke Unit and Neurosonology Laboratory, University of Padua School of Medicine, Padova. Italy
700    1_
$a Skoloudik, David $u Center for Health Research, Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic
700    1_
$a Azevedo, Elsa $u Department of Neurology, Centro Hospitalar de São João, Faculty of Medicine of University of Porto, Portugal
700    1_
$a Kaps, Manfred $u Justus-Liebig-University Giessen, Giessen, Germany
773    0_
$w MED00200144 $t European stroke journal $x 2396-9881 $g Roč. 9, č. 2 (2024), s. 409-417
856    41
$u https://pubmed.ncbi.nlm.nih.gov/38149620 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20240725 $b ABA008
991    __
$a 20240905134340 $b ABA008
999    __
$a ok $b bmc $g 2143550 $s 1225671
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2024 $b 9 $c 2 $d 409-417 $e 20231227 $i 2396-9881 $m European stroke journal $n Eur Stroke J $x MED00200144
LZP    __
$a Pubmed-20240725

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...